Pharmacogenetics and Adverse Events in the Use of Fluoropyrimidine in a Cohort of Cancer Patients on Standard of Care Treatment in Zimbabwe is a research paper published in Journal of Personalized Medicine (2023). On theSindex it has a DataRank of 0. It has been cited 10 times.
Scored on demand from live citation data
Linked data & code
DataRank reads this dataset's downstream impact straight off the citation graph — no black box, no proprietary weighting. How is this computed?
FAIR checklist signals are shown for context only and do not affect DataRank scoring.
We only score data papers we can read in full — never from an abstract alone.
European & Developing Countries Clinical Trials Partnership
Grant: TMA2016SF-1508
European & Developing Countries Clinical Trials Partnership
Grant: ID INV-036801
European & Developing Countries Clinical Trials Partnership
Grant: 5P20CA210677
NCI NIH HHS
Grant: P20 CA210677
Gates Foundation
Grant: INV-036801
National Institutes of Health
Grant: 1P20CA210677-01A1
African Center for the Advancement of Research Excellence (AfriCARE)
FWCI
1.16
Citation Percentile
0.8%
Influential Citations
1
Citation Trend
Fields of Study
Keywords
Sustainable Development Goals